HWM
PMD

HighMark Wealth Management’s Psychemedics Corporation PMD Stock Holding History

HighMark Wealth Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,039
Closed -$14K – 548
2022
Q1 		$14K Sell
2,039
-3,500
-63% -$24.8K 0.01% 219
2021
Q4 		$39K Buy
5,539
+39
+0.7% +$312 0.02% 134
2021
Q3 		$46K Buy
+5,500
New +$40.3K 0.03% 121

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

HighMark Wealth Management's PMD Position: Q2 2022 in Review

HighMark Wealth Management sold out of Psychemedics Corporation (PMD) in Q2 2022, closing a stake of 2,039 shares — an estimated $14K sold.

HighMark Wealth Management first reported a position in PMD in Q3 2021 and held it in 3 quarters. The position peaked at $46K in Q3 2021. 21 funds tracked by Wall St. Rank hold PMD as of Q2 2022.

  • HighMark Wealth Management reported no remaining Psychemedics Corporation position as of Q2 2022 after selling out during the quarter.
  • HighMark Wealth Management sold 2,039 Psychemedics Corporation shares in Q2 2022, an estimated $14K.
  • HighMark Wealth Management first reported a position in Psychemedics Corporation in Q3 2021 and held it in 3 quarters.
  • HighMark Wealth Management's Psychemedics Corporation position peaked at $46K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2022.

Based on HighMark Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.